People interested in taking Wegovy should consider this commitment, as well as the cost that comes with long-term medication use, before using ... Ozempic and Zepbound, after consulting with ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and ...

Always speak with your doctor before starting any ... keeping you on track even after you’re done with the medication.” ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the ...

Few things have stirred up as much commotion in either the weight loss or pharmaceutical world as Ozempic and Wegovy ... of 14.9% of their body weight after 68 weeks, compared with an average ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing ... up existing stock before placing new orders ...

You may have to meet a higher deductible before having weight loss drugs covered because they're often included in your medical benefits, instead of being a prescription benefit. After initial ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after ...

The company is due to release data before the end of this year from a late-stage trial of CagriSema, a two-drug combination obesity treatment that like Wegovy ... the results, after U.S. rival ...